Roche Holding stock heads into the open after a 0.48 percent drop

At the close on September 23, 2026, Roche Holding stock traded at CHF 365.85 on SIX, with a CHF 361.00 to CHF 368.20 range. A kidney-trial update was published during the session.

Roche Holding stock closed at CHF 365.85 on SIX on September 23, 2026, down 0.48 percent from CHF 364.10. The shares finished 0.25 percentage points below the SMI, which closed at 13,921.72 points, down 0.23 percent on the same session date.

September 23, 2026 in numbers

Roche Holding AG (ISIN CH0012032048) opened at CHF 364.60 and traded between CHF 361.00 and CHF 368.20 on September 23, 2026. Volume was 735,610 shares, while the 52-week range stood at CHF 252.20 to CHF 375.80, leaving the close CHF 9.95 below the high.

As Investing.com reported on September 23, 2026, Roche said its sefaxersen phase III study met its primary endpoint in IgA nephropathy. The company said the study showed statistically significant reductions in proteinuria versus placebo and reported no new safety signals.

September 24, 2026 outlook

Switzerland is due to publish its interest-rate decision on September 24, 2026, with the calendar listing a 0 percent rate and a scheduled release at 03:30 Eastern Time. The event is relevant to Roche through its Swiss home market and valuation sensitivity to interest rates, as well as broader healthcare-sector trading.